Artemisinin is widely used in the treatment of malaria, particularly for infections caused by Plasmodium falciparum, which is known for its resistance to other antimalarial drugs. It is a key component in Artemisinin-based Combination Therapies (ACTs), which are recommended by the World Health Organization as the first-line treatment for uncomplicated malaria. The compound works by producing free radicals that damage the malaria parasite, leading to its death. Beyond malaria, research is exploring its potential in treating other diseases, including certain cancers, due to its ability to induce apoptosis in cancer cells. Additionally, artemisinin has shown promise in addressing conditions like schistosomiasis and some viral infections, though these applications are still under investigation. Its derivatives, such as artesunate and artemether, are also utilized in various therapeutic contexts, enhancing its versatility in medical treatments.